U.S. Insurance Stock News

Super Micro Computer’s stock has swung sharply in recent months, yet current valuation checks point in the same direction. Both the Discounted Cash Flow (DCF) intrinsic value estimate and market multiples suggest the shares trade below what the fundamentals imply. Super Micro Computer has delivered a very large 5 year return of about 7x, which sets a high bar for what counts as attractive value today. Expectations around continued AI server demand and a sizable order backlog can support the...

Venture Global (VG) drew fresh attention after announcing new binding agreements with German utility EnBW for approximately 0.82 million tonnes per annum of U.S. LNG over about five years starting in 2026. See our latest analysis for Venture Global. Venture Global’s recent EnBW supply deal lands after a mixed run in the stock, with the share price up 58.10% year to date but the 1 year total shareholder return down 24.90%. This suggests momentum has cooled after a strong early rally. If this...

The renewed access to Anthropic’s Claude Fable 5 and Mythos 5 models, alongside a tougher U.S. regulatory stance on AI, is reshaping how investors look at cloud and enterprise software stocks linked to AI workloads and compliance needs. With export controls lifted, some U.S. AI driven cloud and enterprise software providers are again positioned to build on Anthropic’s latest tools, even as regulatory uncertainty lingers. This article looks at 3 stocks from our U.S. AI Driven Cloud and...

Snap-on (SNA) is back in focus after recent share price gains, with the stock closing at $402.40. Investors are weighing this move against the company’s steady tools, equipment, and diagnostics business model. See our latest analysis for Snap-on. Viewed in context, the recent 1-day share price return of 1.01% and 30-day share price return of 8.40% sit on top of a 1-year total shareholder return of 30.09%, indicating that momentum in Snap-on has been building rather than fading. If Snap-on’s...

Dianthus Therapeutics has initiated the global, randomized, placebo-controlled Phase 3 EMERGE trial of its investigational antibody claseprubart in generalized Myasthenia Gravis, following encouraging Phase 2 MaGic data and recent FDA Orphan Drug Designation for this indication. By targeting only the active form of C1s in the classical complement pathway with an infrequently dosed subcutaneous formulation, claseprubart aims to balance efficacy, infection risk, and convenience for gMG...

Microsoft partnership puts Commvault Systems (CVLT) in focus Commvault Systems (NasdaqGS:CVLT) is in the spotlight after Microsoft agreed to offer its AI driven cyber resilience platform as a native service on Azure, integrating data protection directly into the cloud. See our latest analysis for Commvault Systems. The Azure agreement lands after a sharp run in Commvault Systems’ share price, with a 90 day share price return of 80.75% and a 3 year total shareholder return of 95.65%, while the...

HealthEquity stock moves after index removal and stock offering plans HealthEquity (HQY) has drawn fresh attention after being removed from the Russell 2000 Dynamic Index and filing a US$204.8 million shelf registration for common stock tied to an employee stock ownership plan. For investors following HealthEquity, these two developments sit squarely at the intersection of index related flows and potential equity issuance. Both factors can influence liquidity, trading volumes and how the...

Index additions put Guardian Pharmacy Services in focus Guardian Pharmacy Services (GRDN) has drawn fresh attention after being added to the Russell 2000 Defensive Index and the Russell 2000 Growth Defensive Index, highlighting how index inclusion can influence investor interest and liquidity. See our latest analysis for Guardian Pharmacy Services. Guardian Pharmacy Services has seen buying interest build over the past year, with a 1-year total shareholder return of 95.65% and a year to date...

Why Kilroy Realty Stock Is Back in Focus After a Major Credit Rework Kilroy Realty (KRC) shares are drawing attention after the company closed amended senior unsecured revolving credit and term loan facilities, expanding available borrowing capacity and pushing key debt maturities further into the next decade. See our latest analysis for Kilroy Realty. Against this credit backdrop, Kilroy Realty’s share price has risen 9.34% over the past month and 33.44% over the past 90 days, while its 1...

Federated Hermes (FHI) has drawn fresh attention after launching two actively managed ETFs, including the Ultrashort Bond ETF targeting investment grade debt and the International Leaders ETF focusing on developed market equities. See our latest analysis for Federated Hermes. These ETF launches come as Federated Hermes shares trade at US$55.22. The stock is down over the past week and quarter, but is supported by a positive year to date share price return and strong multi year total...

Harmony Biosciences has recently outlined plans to expand beyond its core sleep drug Wakix by advancing pitolisant into new indications, developing high-dose and gastro-resistant formulations, and progressing additional neuroscience assets such as an orexin-2 receptor agonist and rare epilepsy programs. This push to diversify its portfolio suggests Harmony is working to reduce its reliance on a single product and build a broader neuroscience franchise across sleep and rare neurological...

Hilltop Holdings (HTH) is back in focus after affiliate Momentum Independent Network launched Momentum Financial Institution Services to offer brokerage, advisory, and consulting support tailored to smaller community banks and credit unions. See our latest analysis for Hilltop Holdings. Hilltop Holdings’ share price has a year to date return of 14.40% and a 90 day share price return of 7.75% at a last close of $38.78, while the 1 year total shareholder return of 26.50% points to momentum that...

On 27 June 2026, Precigen, Inc. (NasdaqGS:PGEN) was removed from several Russell value indexes, including the Russell 2000, 2500, 3000, 3000E, Small Cap, and Microcap Value benchmarks. This broad index removal can prompt portfolio rebalancing by passive funds, potentially reshaping who holds the stock and how it trades over time. We’ll now examine how Precigen’s removal from multiple Russell value benchmarks may influence its investment narrative and future investor focus. The future of work...

In late June 2026, Royal Caribbean Cruises Ltd. was added to several Russell value benchmarks, including the Russell 3000 Value, Russell 1000 Value, Russell Midcap Value and Russell 3000E Value indices. Around the same time, the company also announced a partnership with Roald Dahl's Marvellous Children's Charity tied to the upcoming European debut of Legend of the Seas, integrating charitable fundraising into the onboard guest experience. We’ll now examine how Royal Caribbean’s broad...

Why the latest index moves matter for Analog Devices Analog Devices (ADI) is back in focus after a series of index changes and recent earnings, with the stock joining several Russell growth benchmarks while exiting certain defensive and value oriented indices. These moves follow Q2 2026 results that were supported by the Industrial Business segment and Q3 guidance with revenue and adjusted EPS targets above analyst expectations, prompting some investors to reconsider how they classify Analog...

HPE partnership expansion puts ScanSource stock in focus ScanSource (SCSC) is back on investors’ radar after announcing an expanded partnership with HPE that now includes HPE Juniper Networking, broadening its networking, cybersecurity and AI-enabled offerings for channel partners. See our latest analysis for ScanSource. ScanSource’s latest HPE announcement comes after a period of strong momentum, with a 12.6% 1 month share price return and a 42.5% 3 month share price return, while the 5 year...

The current AI boom has pushed high profile stocks such as Caterpillar into the spotlight, with Michael Burry publicly betting against what he sees as stretched valuations. When big investors question the durability of an AI driven rally, it can be a useful moment to look at steadier ideas that rely less on market excitement. This article focuses on defensive value stocks that combine lower volatility with reasonable pricing and dividend potential. You will see 3 stocks from this screener...

Pagaya Technologies recently saw CEO Gal Krubiner buy 16,230 shares on the open market, while the company upsized a US$800 million, AAA-rated personal loan asset-backed securities deal and expanded its partnership with Upgrade to power buy now, pay later offerings at the point of sale. Together, these moves highlight how Pagaya is deepening its role in consumer credit infrastructure by pairing AI-driven underwriting with large-scale capital markets funding and embedded lending...

Index removal puts Insperity in focus for investors Insperity (NSP) has been removed from both the Russell 2000 Defensive Index and the Russell 2000 Growth-Defensive Index, a shift that can influence demand as index-tracking funds adjust their holdings. See our latest analysis for Insperity. Insperity's latest index removal comes after a sharp short term rebound, with the 30 day share price return of 19.84% and 90 day share price return of 52.77% contrasting with a 1 year total shareholder...

RB Global (RBA) has been removed from several Russell growth benchmarks, a shift that can influence trading flows as index tracking funds adjust positions and active managers reassess exposure. See our latest analysis for RB Global. At a share price of $116.45, RB Global has seen firm upward momentum recently, with a 7 day share price return of 7.37% and a 90 day share price return of 20.55%, while the 5 year total shareholder return of 115.53% points to strong longer term compounding. Index...

NeoGenomics (NEO) has drawn fresh attention after appointing Carolyn Starrett to its Board of Directors, bringing her extensive experience in AI driven data insights and cancer care to the company’s governance. See our latest analysis for NeoGenomics. Against this backdrop, NeoGenomics’ momentum has been strong, with a 90 day share price return of 82.38% and a 1 year total shareholder return of 97.16%, while 3 and 5 year total shareholder returns remain weak. If you’re assessing how AI and...

Recent Performance Snapshot for Barrick Mining Barrick Mining (B) has drawn attention after its share price closed at US$36.73, with the stock down about 14% over the past month and about 13% over the past 3 months. Over a longer horizon, Barrick Mining shows a 1 year total return of about 80%, alongside reported annual revenue of US$19,044 and net income of US$6,121. This combination gives investors a mix of recent pressure and stronger multi year performance. See our latest analysis for...

Index inclusion puts Rogers in focus Rogers (ROG) is back on investor radars after being added to the Russell 2000 Dynamic Index, a move that can influence trading activity as index-tracking funds adjust positions. The stock has climbed about 16% over the past month and roughly 54% in the past 3 months, drawing attention to how Rogers is valued against its fundamentals as new index-linked demand develops. See our latest analysis for Rogers. Beyond the latest index inclusion, Rogers has seen...

Nuclear energy stocks sit at the crossroads of energy security, inflation pressures and long term demand for reliable power. With central banks watching mixed inflation data, energy and commodity costs are still a key focus for many investors. Our Nuclear Energy Stocks screener helps you filter this broad theme down to companies directly involved in uranium production, enrichment and reactor operations, so you are not starting from scratch. In this article, you will see three stocks from the...